Publications

Blake S Moses*, William L Slone*, Patrick Thomas, Rebecca Evans, Debbie Piktel, Peggi M Angel, Callee M Walsh, Pamela S Cantrell, Stephanie L Rellick, Karen H Martin, James W Simpkins, and Laura F Gibson. Bone Marrow Microenvironment Modulation of Acute Lymphoblastic Leukemia Phenotype. Experimental Hematology. In Press.

Slone William L.*, Moses Blake S.*, Evans Rebecca, Piktel Debbie, Martin Karen H., Petros William, Craig Michael, and Gibson Laura F. Modeling chemotherapy resistant leukemia in vitro. JOVE. In Press.

Bruce A, Evans R, Mezan R, Shi L, Moses BS, Martin KH, et al. (2015) Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia. PLoS ONE 10(10): e0140506. doi:10.1371/journal.pone.0140506

Evans R, Martin KH, Moses BS, Slone WL, Hare I, Piktel D, Thomas P, and Gibson LF. Modeling The Bone Marrow Microenvironment’s Influence on Leukemia Disease. Translational Biomedicine. Vol. 6 No. 2:14. 2015

Ian Hare, Marieta Gencheva, Rebecca Evans, James Fortney, Debbie Piktel, Jeffrey Vos, David Howell, Laura F Gibson. 2015. “In vitro expansion of bone marrow derived mesenchymal stem cells alters DNA double strand break repair of etoposide induced DNA damage” Stem Cells International. In Press.

Moses BS, Slone WL, Thomas P, Evans R, Piktel D, Angel PM, Walsh CM, Cantrell PS, Rellick SL, Martin KH, Simpkins JW, Gibson LF. Bone Marrow Microenvironment Modulation of Acute Lymphoblastic Leukemia Phenotype.Exp Hematol. 2015 Sep 25.

Slone, W. L., Moses, B. S., Evans, R., Piktel, D., Martin, K. H., Petros, W., et al. Modeling Chemotherapy Resistant Leukemia in vitro. J. Vis. Exp. (), e53645, doi:10.3791/53645 (2015).

Bruce A, Evans R, Mezan R, Shi L, Moses BS, Martin KH, et al. (2015) Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia. PLoS ONE 10(10): e0140506. doi:10.1371/journal.pone.0140506

Evans R, Martin KH, Moses BS, Slone WL, Hare I, Piktel D, Thomas P, and Gibson LF. Modeling The Bone Marrow Microenvironment’s Influence on Leukemia Disease. Translational Biomedicine. Vol. 6 No. 2:14. 2015

Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W.

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

Oncotarget. 2015 Aug 21;6(24):20697-710.

Rubenstein JN, Beatty C, Kinkade Z, Bryan C, Hogg JP, Gibson LF, Vos JA.

Extranodal Marginal Zone Lymphoma of the Lung: Evolution from an Underlying Reactive Lymphoproliferative Disorder.J Clin Exp Pathol. 2015 Feb;5(1).

Jajosky, A. N., Coad, J. E., Vos, J. A., Martin, K. H., Senft, J. R., Wenger, S. L., & Gibson, L. F. (2014). RepSox Slows Decay of CD34+ Acute Myeloid Leukemia Cells and Decreases T Cell Immunoglobulin Mucin-3 Expression.Stem Cells Translational Medicine, sctm-2013.

Basu SK, Remick SC, Monga M, Gibson LF. Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.Clin Exp Metastasis. 2014 Feb;31(2):257-67. doi: 10.1007/s10585-013-9623-4. Epub 2013 Dec 5. Review.

Gencheva, M., Hare, I., Kurian, S., Fortney, J., Piktel, D., Wysolmerski, R. and Gibson, L. F. (2013), Bone marrow osteoblast vulnerability to chemotherapy. European Journal of Haematology, 90: 469–478. doi: 10.1111/ejh.12109

M. Li, S. K. Cushing, J. Zhang, S. Suri, R. Evans, W. P. Petros, L. F. Gibson, D. Ma, Y. Liu, and N. Q. Wu. Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immuno-sensor for cancer biomarker detection in blood plasma. ACS Nano, 7 (2013), 4967-4976.

Hamadani M, Gibson LF, Remick SC, Wen S, Petros W, Tse W, Brundage KM, Vos JA, Cumpston A, Bunner P, Craig MD. Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease. J Clin Oncol. 2013 Dec 10;31(35):4416-23. doi: 10.1200/JCO.2013.50.8747. Epub 2013 Oct 28

Rellick SL, O'Leary H, Piktel D, Walton C, Fortney JE, Akers SM, Martin KH, Denvir J, Boskovic G, Primerano DA, Vos J, Bailey N, Gencheva M, Gibson LF. Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758

Awan FT, Osman S, Kochuparambil ST, Gibson L, Remick SC, Abraham J, Craig M, Jillella A, Hamadani M. Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation. Bone Marrow Transplant. 2011 Feb 28.

Hamadani M, Craig M, Phillips GS, Abraham J, Tse W, Cumpston A, Gibson L, Remick SC, Bunner P, Leadmon S, Elder P, Hofmeister C, Penza S, Efebera Y, Andritsos L, Garzon R, Benson DM Jr, Blum W, Devine SM. Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning. Hematol Oncol. 2011 Feb 28.

Akers SM, Rellick SL, Fortney JE, Gibson LF. Cellular elements of the subarachnoid space promote ALL survival during chemotherapy. Leuk Res. 2011 Jun;35(6):705-11. Epub 2011 Jan 26.

Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G. Respiratory syncytial virus infection in human bone marrow stromal cells. Am J Respir Cell Mol Biol. 2011 Aug;45(2):277-86.

Akers SM, O'Leary HA, Minnear FL, Craig MD, Vos JA, Coad JE, Gibson LF.VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers. Exp Hematol. 2010; 38(9):733-43.

Rezaee F, Rellick SL, Piedimonte G, Akers SM, O'Leary HA, Martin K, Craig MD, Gibson LF. Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One. 2010; 15;5(3):e9690.

O'Leary H, Akers SM, Piktel D, Walton C, Fortney JE, Martin KH, Craig M, Coad JE, Gibson LF. VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis. Cancer Microenvironment. 2010; 3:67-81.